Updates
** New Zealand's Fisher & Paykel Healthcare FPH.NZ falls 1.7% to NZ$36.13, loses 0.8% for the week
** Stock set for weakest week since April 5
** Jefferies downgrades to "hold" from "buy", keeps PT unchanged at NZ$39.40
** Says it's interested in knowing impact of U.S. tariffs to date, when co reports FY25 results on May 28; will closely watch co's mitigation strategies
** Notes, "We understand the primary impact on FPH imports is currently a 10% tariff on New Zealand products"
** Stock rated "hold" on avg; median PT is NZ$35.81, per data compiled by LSEG
** YTD, FPH falls ~6%
(Reporting by Roshan Thomas and Nikita Maria Jino in Bengaluru)
((Roshan.Thomas@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。